A Diversity of OXA-Carbapenemases and Class 1 Integrons Among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates from Sweden Belonging to …

N Karah, CG Giske, A Sundsfjord… - Microbial drug …, 2011 - liebertpub.com
This study was aimed to investigate the molecular epidemiology, mechanism of carbapenem
resistance, and occurrence of class 1 integrons among 13 carbapenem-resistant clinical …

A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different …

N Karah, CG Giske, A Sundsfjord… - Microbial drug …, 2011 - pubmed.ncbi.nlm.nih.gov
This study was aimed to investigate the molecular epidemiology, mechanism of carbapenem
resistance, and occurrence of class 1 integrons among 13 carbapenem-resistant clinical …

A Diversity of OXA-Carbapenemases and Class 1 Integrons Among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates from Sweden Belonging to …

N Karah, CG Giske, A Sundsfjord… - Microbial Drug …, 2011 - search.proquest.com
This study was aimed to investigate the molecular epidemiology, mechanism of carbapenem
resistance, and occurrence of class 1 integrons among 13 carbapenem-resistant clinical …

A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different …

N Karah, CG Giske, A Sundsfjord, Ø Samuelsen - 2011 - cabidigitallibrary.org
This study was aimed to investigate the molecular epidemiology, mechanism of carbapenem
resistance, and occurrence of class 1 integrons among 13 carbapenem-resistant clinical …

A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different …

N Karah, CG Giske, A Sundsfjord… - Microbial Drug …, 2011 - europepmc.org
This study was aimed to investigate the molecular epidemiology, mechanism of carbapenem
resistance, and occurrence of class 1 integrons among 13 carbapenem-resistant clinical …